Fair Value Measurement | 12 Months Ended |
Dec. 31, 2014 |
Fair Value Disclosures [Abstract] | |
Fair value measurement | Fair value measurement |
JPMorgan Chase carries a portion of its assets and liabilities at fair value. These assets and liabilities are predominantly carried at fair value on a recurring basis (i.e., assets and liabilities that are measured and reported at fair value on the Firm’s Consolidated balance sheets). Certain assets (e.g., certain mortgage, home equity and other loans where the carrying value is based on the fair value of the underlying collateral), liabilities and unfunded lending-related commitments are measured at fair value on a nonrecurring basis; that is, they are not measured at fair value on an ongoing basis but are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). |
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is based on quoted market prices, where available. If listed prices or quotes are not available, fair value is based on models that consider relevant transaction characteristics (such as maturity) and use as inputs observable or unobservable market parameters, including but not limited to yield curves, interest rates, volatilities, equity or debt prices, foreign exchange rates and credit curves. Valuation adjustments may be made to ensure that financial instruments are recorded at fair value, as described below. |
The level of precision in estimating unobservable market inputs or other factors can affect the amount of gain or loss recorded for a particular position. Furthermore, while the Firm believes its valuation methods are appropriate and consistent with those of other market participants, the methods and assumptions used reflect management judgment and may vary across the Firm’s businesses and portfolios. |
The Firm uses various methodologies and assumptions in the determination of fair value. The use of different methodologies or assumptions to those used by the Firm could result in a different estimate of fair value at the reporting date. |
Valuation process |
Risk-taking functions are responsible for providing fair value estimates for assets and liabilities carried on the Consolidated balance sheets at fair value. The Firm’s valuation control function, which is part of the Firm’s Finance function and independent of the risk-taking functions, is responsible for verifying these estimates and determining any fair value adjustments that may be required to ensure that the Firm’s positions are recorded at fair value. In addition, the Firm has a firmwide Valuation Governance Forum (“VGF”) comprised of senior finance and risk executives to oversee the management of risks arising from valuation activities conducted across the Firm. The VGF is chaired by the Firmwide head of the valuation control function, and also includes sub-forums for the Corporate & Investment Bank (“CIB”), Mortgage Banking, (part of Consumer & Community Banking) and certain corporate functions including Treasury and Chief Investment Office (“CIO”). |
The valuation control function verifies fair value estimates provided by the risk-taking functions by leveraging independently derived prices, valuation inputs and other market data, where available. Where independent prices or inputs are not available, additional review is performed by the valuation control function to ensure the reasonableness of the estimates, and may include: evaluating the limited market activity including client unwinds; benchmarking of valuation inputs to those for similar instruments; decomposing the valuation of structured instruments into individual components; comparing expected to actual cash flows; reviewing profit and loss trends; and reviewing trends in collateral valuation. In addition there are additional levels of management review for more significant or complex positions. |
The valuation control function determines any valuation adjustments that may be required to the estimates provided by the risk-taking functions. No adjustments are applied to the quoted market price for instruments classified within level 1 of the fair value hierarchy (see below for further information on the fair value hierarchy). For other positions, judgment is required to assess the need for valuation adjustments to appropriately reflect liquidity considerations, unobservable parameters, and, for certain portfolios that meet specified criteria, the size of the net open risk position. The determination of such adjustments follows a consistent framework across the Firm: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | Liquidity valuation adjustments are considered where an observable external price or valuation parameter exists but is of lower reliability, potentially due to lower market activity. Liquidity valuation adjustments are applied and determined based on current market conditions. Factors that may be considered in determining the liquidity adjustment include analysis of: (1) the estimated bid-offer spread for the instrument being traded; (2) alternative pricing points for similar instruments in active markets; and (3) the range of reasonable values that the price or parameter could take. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The Firm manages certain portfolios of financial instruments on the basis of net open risk exposure and, as permitted by U.S. GAAP, has elected to estimate the fair value of such portfolios on the basis of a transfer of the entire net open risk position in an orderly transaction. Where this is the case, valuation adjustments may be necessary to reflect the cost of exiting a larger-than-normal market-size net open risk position. Where applied, such adjustments are based on factors that a relevant market participant would consider in the transfer of the net open risk position including the size of the adverse market move that is likely to occur during the period required to reduce the net open risk position to a normal market-size. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | Unobservable parameter valuation adjustments may be made when positions are valued using prices or input parameters to valuation models that are unobservable due to a lack of market activity or because they cannot be implied from observable market data. Such prices or parameters must be estimated and are, therefore, subject to management judgment. Unobservable parameter valuation adjustments are applied to reflect the uncertainty inherent in the resulting valuation estimate. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Where appropriate, the Firm also applies adjustments to its estimates of fair value in order to appropriately reflect counterparty credit quality, the Firm’s own creditworthiness and the impact of funding, applying a consistent framework across the Firm. For more information on such adjustments see Credit and funding adjustments on pages 196–197 of this Note. |
Valuation model review and approval |
If prices or quotes are not available for an instrument or a similar instrument, fair value is generally determined using valuation models that consider relevant transaction data such as maturity and use as inputs market-based or independently sourced parameters. Where this is the case the price verification process described above is applied to the inputs to those models. |
The Model Risk function is independent of the model owners and reviews and approves a wide range of models, including risk management, valuation and certain regulatory capital models used by the Firm. The Model Risk function is part of the Firm’s Model Risk and Development unit, and the Firmwide Model Risk and Development Executive reports to the Firm’s CRO. When reviewing a model, the Model Risk function analyzes and challenges the model methodology and the reasonableness of model assumptions and may perform or require additional testing, including back-testing of model outcomes. |
New significant valuation models, as well as material changes to existing valuation models, are reviewed and approved prior to implementation except where specified conditions are met. The Model Risk function performs an annual firmwide model risk assessment where developments in the product or market are considered in determining whether valuation models which have already been reviewed need to be reviewed and approved again. |
Valuation hierarchy |
A three-level valuation hierarchy has been established under U.S. GAAP for disclosure of fair value measurements. The valuation hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The three levels are defined as follows. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | Level 1 – inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | Level 2 – inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | Level 3 – one or more inputs to the valuation methodology are unobservable and significant to the fair value measurement. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
A financial instrument’s categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. |
The following table describes the valuation methodologies used by the Firm to measure its more significant products/instruments at fair value, including the general classification of such instruments pursuant to the valuation hierarchy. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Product/instrument | Valuation methodology | Classifications in the valuation hierarchy | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Securities financing agreements | Valuations are based on discounted cash flows, which consider: | Level 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Derivative features. For further information refer to the | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
discussion of derivatives below. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Market rates for the respective maturity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Collateral | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Loans and lending-related commitments - wholesale | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Trading portfolio | Where observable market data is available, valuations are based on: | Level 2 or 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Observed market prices (circumstances are infrequent) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Relevant broker quotes | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Observed market prices for similar instruments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Where observable market data is unavailable or limited, valuations are based on discounted cash flows, which consider the following: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Yield | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Lifetime credit losses | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Loss severity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Prepayment speed | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Servicing costs | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Loans held for investment and associated lending-related commitments | Valuations are based on discounted cash flows, which consider: | Predominantly level 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Credit spreads, derived from the cost of credit default swaps (“CDS”); or benchmark credit curves developed by the Firm, by industry and credit rating, and which take into account the difference in loss severity rates between bonds and loans | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Prepayment speed | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Lending-related commitments are valued similar to loans and reflect the portion of an unused commitment expected, based on the Firm’s average portfolio historical experience, to become funded prior to an obligor default | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For information regarding the valuation of loans measured at collateral value, see Note 14. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Loans - consumer | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Held for investment consumer loans, excluding credit card | Valuations are based on discounted cash flows, which consider: | Predominantly level 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Discount rates (derived from primary origination rates and market activity) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Expected lifetime credit losses (considering expected and current default rates for existing portfolios, collateral prices, and economic environment expectations (e.g., unemployment rates)) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Estimated prepayments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Servicing costs | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Market liquidity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For information regarding the valuation of loans measured at collateral value, see Note 14. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Held for investment credit card receivables | Valuations are based on discounted cash flows, which consider: | Level 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Projected interest income and late fee revenue, servicing and credit costs, and loan repayment rates | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Estimated life of receivables (based on projected loan payment rates) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Discount rate - based on cost of funding and expected return on receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Credit costs - allowance for loan losses is considered a reasonable proxy for the credit cost based on the short-term nature of credit card receivables | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Trading loans - Conforming residential mortgage loans expected to be sold | Fair value is based upon observable prices for mortgage-backed securities with similar collateral and incorporates adjustments to these prices to account for differences between the securities and the value of the underlying loans, which include credit characteristics, portfolio composition, and liquidity. | Predominantly level 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Product/instrument | Valuation methodology, inputs and assumptions | Classifications in the valuation hierarchy | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Securities | Quoted market prices are used where available. | Level 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| In the absence of quoted market prices, securities are valued based on: | Level 2 or 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Observable market prices for similar securities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Relevant broker quotes | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Discounted cash flows | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| In addition, the following inputs to discounted cash flows are used for the following products: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Mortgage- and asset-backed securities specific inputs: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collateral characteristics | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Deal-specific payment and loss allocations | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Current market assumptions related to yield, prepayment speed, conditional default rates and loss severity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Collateralized loan obligations (“CLOs”), specific inputs: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collateral characteristics | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Deal-specific payment and loss allocations | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Expected prepayment speed, conditional default rates, loss severity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Credit spreads | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Credit rating data | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Physical commodities | Valued using observable market prices or data | Predominantly Level 1 and 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives | Exchange-traded derivatives that are actively traded and valued using the exchange price, and over-the-counter contracts where quoted prices are available in an active market. | Level 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Derivatives that are valued using models such as the Black-Scholes option pricing model, simulation models, or a combination of models, that use observable or unobservable valuation inputs (e.g., plain vanilla options and interest rate and credit default swaps). Inputs include: | Level 2 or 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Contractual terms including the period to maturity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Readily observable parameters including interest rates and volatility | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Credit quality of the counterparty and of the Firm | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Market funding levels | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Correlation levels | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| In addition, the following specific inputs are used for the following derivatives that are valued based on models with significant unobservable inputs: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Structured credit derivatives specific inputs include: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CDS spreads and recovery rates | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Credit correlation between the underlying debt instruments (levels are modeled on a transaction basis and calibrated to liquid benchmark tranche indices) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Actual transactions, where available, are used to regularly recalibrate unobservable parameters | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Certain long-dated equity option specific inputs include: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Long-dated equity volatilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Certain interest rate and foreign exchange (“FX”) exotic options specific inputs include: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate correlation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate spread volatility | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Foreign exchange correlation | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Correlation between interest rates and foreign exchange rates | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Parameters describing the evolution of underlying interest rates | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Certain commodity derivatives specific inputs include: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Commodity volatility | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • Forward commodity price | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Additionally, adjustments are made to reflect counterparty credit quality (credit valuation adjustments or “CVA”), the Firm’s own creditworthiness (debit valuation adjustments or “DVA”), and funding valuation adjustment (“FVA”) to incorporate the impact of funding. See pages 196–197 of this Note. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Product/instrument | Valuation methodology, inputs and assumptions | Classification in the valuation hierarchy | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Mortgage servicing rights (“MSRs”) | See Mortgage servicing rights in Note 17. | Level 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Private equity direct investments | Private equity direct investments | Level 2 or 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Fair value is estimated using all available information and considering the range of potential inputs, including: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Transaction prices | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Trading multiples of comparable public companies | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • Operating performance of the underlying portfolio company | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Additional available inputs relevant to the investment | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Adjustments as required, since comparable public companies are not identical to the company being valued, and for company-specific issues and lack of liquidity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Public investments held in the Private Equity portfolio | Level 1 or 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Valued using observable market prices less adjustments for relevant restrictions, where applicable | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fund investments (i.e., mutual/collective investment funds, private equity funds, hedge funds, and real estate funds) | Net asset value (“NAV”) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | Level 1 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| NAV is validated by sufficient level of observable activity (i.e., purchases and sales) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | Level 2 or 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Adjustments to the NAV as required, for restrictions on redemption (e.g., lock up periods or withdrawal limitations) or where observable activity is limited | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Beneficial interests issued by consolidated VIEs | Valued using observable market information, where available | Level 2 or 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| In the absence of observable market information, valuations are based on the fair value of the underlying assets held by the VIE | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Long-term debt, not carried at fair value | Valuations are based on discounted cash flows, which consider: | Predominantly level 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Market rates for respective maturity | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | • The Firm’s own creditworthiness (DVA). See pages 196-197 of this Note. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Structured notes (included in deposits, other borrowed funds and long-term debt) | • Valuations are based on discounted cash flow analyses that consider the embedded derivative and the terms and payment structure of the note. | Level 2 or 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| • The embedded derivative features are considered using models such as the Black-Scholes option pricing model, simulation models, or a combination of models that use observable or unobservable valuation inputs, depending on the embedded derivative. The specific inputs used vary according to the nature of the embedded derivative features, as described in the discussion above regarding derivative valuation. Adjustments are then made to this base valuation to reflect the Firm’s own creditworthiness (DVA) and to incorporate the impact of funding (FVA). See pages 196–197 of this Note. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
The following table presents the asset and liabilities reported at fair value as of December 31, 2014 and 2013, by major product category and fair value hierarchy. |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Assets and liabilities measured at fair value on a recurring basis | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| Fair value hierarchy | | | | | | | | | | | | | | | | | | |
December 31, 2014 (in millions) | Level 1 | Level 2 | | Level 3 | | Derivative netting adjustments | Total fair value | | | | | | | | | | | | | | | |
Federal funds sold and securities purchased under resale agreements | $ | — | | $ | 28,585 | | | $ | — | | | $ | — | | $ | 28,585 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Securities borrowed | — | | 992 | | | — | | | — | | 992 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Trading assets: | | | | | | | | | | | | | | | | | | | | | | |
Debt instruments: | | | | | | | | | | | | | | | | | | | | | | |
Mortgage-backed securities: | | | | | | | | | | | | | | | | | | | | | | |
U.S. government agencies(a) | 14 | | 31,904 | | | 922 | | | — | | 32,840 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Residential – nonagency | — | | 1,381 | | | 663 | | | — | | 2,044 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commercial – nonagency | — | | 927 | | | 306 | | | — | | 1,233 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total mortgage-backed securities | 14 | | 34,212 | | | 1,891 | | | — | | 36,117 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
U.S. Treasury and government agencies(a) | 17,816 | | 8,460 | | | — | | | — | | 26,276 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Obligations of U.S. states and municipalities | — | | 9,298 | | | 1,273 | | | — | | 10,571 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Certificates of deposit, bankers’ acceptances and commercial paper | — | | 1,429 | | | — | | | — | | 1,429 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Non-U.S. government debt securities | 25,854 | | 27,294 | | | 302 | | | — | | 53,450 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Corporate debt securities | — | | 28,099 | | | 2,989 | | | — | | 31,088 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Loans(b) | — | | 23,080 | | | 13,287 | | | — | | 36,367 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Asset-backed securities | — | | 3,088 | | | 1,264 | | | — | | 4,352 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total debt instruments | 43,684 | | 134,960 | | | 21,006 | | | — | | 199,650 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity securities | 104,890 | | 748 | | | 431 | | | — | | 106,069 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Physical commodities(c) | 2,739 | | 1,741 | | | 2 | | | — | | 4,482 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other | — | | 8,762 | | | 1,050 | | | — | | 9,812 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total debt and equity instruments(d) | 151,313 | | 146,211 | | | 22,489 | | | — | | 320,013 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Derivative receivables: | | | | | | | | | | | | | | | | | | | | | | |
Interest rate | 473 | | 951,901 | | | 4,149 | | | (922,798 | ) | 33,725 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Credit | — | | 73,853 | | | 2,989 | | | (75,004 | ) | 1,838 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Foreign exchange | 758 | | 205,887 | | | 2,276 | | | (187,668 | ) | 21,253 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity | — | | 44,240 | | | 2,552 | | | (38,615 | ) | 8,177 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commodity | 247 | | 42,807 | | | 599 | | | (29,671 | ) | 13,982 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total derivative receivables(e) | 1,478 | | 1,318,688 | | | 12,565 | | | (1,253,756 | ) | 78,975 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total trading assets | 152,791 | | 1,464,899 | | | 35,054 | | | (1,253,756 | ) | 398,988 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Available-for-sale securities: | | | | | | | | | | | | | | | | | | | | | | |
Mortgage-backed securities: | | | | | | | | | | | | | | | | | | | | | | |
U.S. government agencies(a) | — | | 65,319 | | | — | | | — | | 65,319 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Residential – nonagency | — | | 50,865 | | | 30 | | | — | | 50,895 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commercial – nonagency | — | | 21,009 | | | 99 | | | — | | 21,108 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total mortgage-backed securities | — | | 137,193 | | | 129 | | | — | | 137,322 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
U.S. Treasury and government agencies(a) | 13,591 | | 54 | | | — | | | — | | 13,645 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Obligations of U.S. states and municipalities | — | | 30,068 | | | — | | | — | | 30,068 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Certificates of deposit | — | | 1,103 | | | — | | | — | | 1,103 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Non-U.S. government debt securities | 24,074 | | 28,669 | | | — | | | — | | 52,743 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Corporate debt securities | — | | 18,532 | | | — | | | — | | 18,532 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Asset-backed securities: | | | | | | | | | | | | | | | | | | | | | | |
Collateralized loan obligations | — | | 29,402 | | | 792 | | | — | | 30,194 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other | — | | 12,499 | | | 116 | | | — | | 12,615 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity securities | 2,530 | | — | | | — | | | — | | 2,530 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total available-for-sale securities | 40,195 | | 257,520 | | | 1,037 | | | — | | 298,752 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Loans | — | | 70 | | | 2,541 | | | — | | 2,611 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Mortgage servicing rights | — | | — | | | 7,436 | | | — | | 7,436 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other assets: | | | | | | | | | | | | | | | | | | | | | | |
Private equity investments(f) | 648 | | 2,624 | | | 2,475 | | | — | | 5,747 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
All other | 4,018 | | 230 | | | 2,371 | | | — | | 6,619 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total other assets | 4,666 | | 2,854 | | | 4,846 | | | — | | 12,366 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total assets measured at fair value on a recurring basis | $ | 197,652 | | $ | 1,754,920 | | (g) | $ | 50,914 | | (g) | $ | (1,253,756 | ) | $ | 749,730 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Deposits | $ | — | | $ | 5,948 | | | $ | 2,859 | | | $ | — | | $ | 8,807 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Federal funds purchased and securities loaned or sold under repurchase agreements | — | | 2,979 | | | — | | | — | | 2,979 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other borrowed funds | — | | 13,286 | | | 1,453 | | | — | | 14,739 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Trading liabilities: | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Debt and equity instruments(d) | 62,914 | | 18,713 | | | 72 | | | — | | 81,699 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Derivative payables: | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Interest rate | 499 | | 920,623 | | | 3,523 | | | (906,900 | ) | 17,745 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Credit | — | | 73,095 | | | 2,800 | | | (74,302 | ) | 1,593 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Foreign exchange | 746 | | 214,800 | | | 2,802 | | | (195,378 | ) | 22,970 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity | — | | 46,228 | | | 4,337 | | | (38,825 | ) | 11,740 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commodity | 141 | | 44,318 | | | 1,164 | | | (28,555 | ) | 17,068 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total derivative payables(e) | 1,386 | | 1,299,064 | | | 14,626 | | | (1,243,960 | ) | 71,116 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total trading liabilities | 64,300 | | 1,317,777 | | | 14,698 | | | (1,243,960 | ) | 152,815 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Accounts payable and other liabilities | — | | — | | | 36 | | | — | | 36 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Beneficial interests issued by consolidated VIEs | — | | 1,016 | | | 1,146 | | | — | | 2,162 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Long-term debt | — | | 18,349 | | | 11,877 | | | — | | 30,226 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total liabilities measured at fair value on a recurring basis | $ | 64,300 | | $ | 1,359,355 | | | $ | 32,069 | | | $ | (1,243,960 | ) | $ | 211,764 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fair value hierarchy | | | | | | | | | | | | | | | | | | |
December 31, 2013 (in millions) | Level 1 | Level 2 | | Level 3 | | Derivative netting adjustments | Total fair value | | | | | | | | | | | | | | | |
Federal funds sold and securities purchased under resale agreements | $ | — | | $ | 25,135 | | | $ | — | | | $ | — | | $ | 25,135 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Securities borrowed | — | | 3,739 | | | — | | | — | | 3,739 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Trading assets: | | | | | | | | | | | | | | | | | | | | | | |
Debt instruments: | | | | | | | | | | | | | | | | | | | | | | |
Mortgage-backed securities: | | | | | | | | | | | | | | | | | | | | | | |
U.S. government agencies(a) | 4 | | 25,582 | | | 1,005 | | | — | | 26,591 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Residential – nonagency | — | | 1,749 | | | 726 | | | — | | 2,475 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commercial – nonagency | — | | 871 | | | 432 | | | — | | 1,303 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total mortgage-backed securities | 4 | | 28,202 | | | 2,163 | | | — | | 30,369 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
U.S. Treasury and government agencies(a) | 14,933 | | 10,547 | | | — | | | — | | 25,480 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Obligations of U.S. states and municipalities | — | | 6,538 | | | 1,382 | | | — | | 7,920 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Certificates of deposit, bankers’ acceptances and commercial paper | — | | 3,071 | | | — | | | — | | 3,071 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Non-U.S. government debt securities | 25,762 | | 22,379 | | | 143 | | | — | | 48,284 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Corporate debt securities(h) | — | | 24,802 | | | 5,920 | | | — | | 30,722 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Loans(b) | — | | 17,331 | | | 13,455 | | | — | | 30,786 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Asset-backed securities | — | | 3,647 | | | 1,272 | | | — | | 4,919 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total debt instruments | 40,699 | | 116,517 | | | 24,335 | | | — | | 181,551 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity securities | 107,667 | | 954 | | | 885 | | | — | | 109,506 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Physical commodities(c) | 4,968 | | 5,217 | | | 4 | | | — | | 10,189 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other | — | | 5,659 | | | 2,000 | | | — | | 7,659 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total debt and equity instruments(d) | 153,334 | | 128,347 | | | 27,224 | | | — | | 308,905 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Derivative receivables: | | | | | | | | | | | | | | | | | | | | | | |
Interest rate | 419 | | 848,862 | | | 5,398 | | | (828,897 | ) | 25,782 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Credit | — | | 79,754 | | | 3,766 | | | (82,004 | ) | 1,516 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Foreign exchange | 434 | | 151,521 | | | 1,644 | | | (136,809 | ) | 16,790 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity | — | | 45,892 | | | 7,039 | | | (40,704 | ) | 12,227 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commodity | 320 | | 34,696 | | | 722 | | | (26,294 | ) | 9,444 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total derivative receivables(e) | 1,173 | | 1,160,725 | | | 18,569 | | | (1,114,708 | ) | 65,759 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total trading assets | 154,507 | | 1,289,072 | | | 45,793 | | | (1,114,708 | ) | 374,664 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Available-for-sale securities: | | | | | | | | | | | | | | | | | | | | | | |
Mortgage-backed securities: | | | | | | | | | | | | | | | | | | | | | | |
U.S. government agencies(a) | — | | 77,815 | | | — | | | — | | 77,815 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Residential – nonagency | — | | 61,760 | | | 709 | | | — | | 62,469 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commercial – nonagency | — | | 15,900 | | | 525 | | | — | | 16,425 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total mortgage-backed securities | — | | 155,475 | | | 1,234 | | | — | | 156,709 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
U.S. Treasury and government agencies(a) | 21,091 | | 298 | | | — | | | — | | 21,389 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Obligations of U.S. states and municipalities | — | | 29,461 | | | — | | | — | | 29,461 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Certificates of deposit | — | | 1,041 | | | — | | | — | | 1,041 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Non-U.S. government debt securities | 25,648 | | 30,600 | | | — | | | — | | 56,248 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Corporate debt securities | — | | 21,512 | | | — | | | — | | 21,512 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Asset-backed securities: | | | | | | | | | | | | | | | | | | | | | | |
Collateralized loan obligations | — | | 27,409 | | | 821 | | | — | | 28,230 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other | — | | 11,978 | | | 267 | | | — | | 12,245 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity securities | 3,142 | | — | | | — | | | — | | 3,142 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total available-for-sale securities | 49,881 | | 277,774 | | | 2,322 | | | — | | 329,977 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Loans | — | | 80 | | | 1,931 | | | — | | 2,011 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Mortgage servicing rights | — | | — | | | 9,614 | | | — | | 9,614 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other assets: | | | | | | | | | | | | | | | | | | | | | | |
Private equity investments(f) | 606 | | 429 | | | 6,474 | | | — | | 7,509 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
All other | 4,213 | | 289 | | | 3,176 | | | — | | 7,678 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total other assets | 4,819 | | 718 | | | 9,650 | | | — | | 15,187 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total assets measured at fair value on a recurring basis | $ | 209,207 | | $ | 1,596,518 | | (g) | $ | 69,310 | | (g) | $ | (1,114,708 | ) | $ | 760,327 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Deposits | $ | — | | $ | 4,369 | | | $ | 2,255 | | | $ | — | | $ | 6,624 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Federal funds purchased and securities loaned or sold under repurchase agreements | — | | 5,426 | | | — | | | — | | 5,426 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Other borrowed funds | — | | 11,232 | | | 2,074 | | | — | | 13,306 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Trading liabilities: | | | | | | | | | | | | | | | | | | | | | | |
Debt and equity instruments(d) | 61,262 | | 19,055 | | | 113 | | | — | | 80,430 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Derivative payables: | | | | | | | | | | | | | | | | | | | | | | |
Interest rate | 321 | | 822,014 | | | 3,019 | | | (812,071 | ) | 13,283 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Credit | — | | 78,731 | | | 3,671 | | | (80,121 | ) | 2,281 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Foreign exchange | 443 | | 156,838 | | | 2,844 | | | (144,178 | ) | 15,947 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Equity | — | | 46,552 | | | 8,102 | | | (39,935 | ) | 14,719 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Commodity | 398 | | 36,609 | | | 607 | | | (26,530 | ) | 11,084 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total derivative payables(e) | 1,162 | | 1,140,744 | | | 18,243 | | | (1,102,835 | ) | 57,314 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total trading liabilities | 62,424 | | 1,159,799 | | | 18,356 | | | (1,102,835 | ) | 137,744 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Accounts payable and other liabilities | — | | — | | | 25 | | | — | | 25 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Beneficial interests issued by consolidated VIEs | — | | 756 | | | 1,240 | | | — | | 1,996 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Long-term debt | — | | 18,870 | | | 10,008 | | | — | | 28,878 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
Total liabilities measured at fair value on a recurring basis | $ | 62,424 | | $ | 1,200,452 | | | $ | 33,958 | | | $ | (1,102,835 | ) | $ | 193,999 | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | At December 31, 2014 and 2013, included total U.S. government-sponsored enterprise obligations of $84.1 billion and $91.5 billion, respectively, which were predominantly mortgage-related. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(b) | At December 31, 2014 and 2013, included within trading loans were $17.0 billion and $14.8 billion, respectively, of residential first-lien mortgages, and $5.8 billion and $2.1 billion, respectively, of commercial first-lien mortgages. Residential mortgage loans include conforming mortgage loans originated with the intent to sell to U.S. government agencies of $7.7 billion and $6.0 billion, respectively, and reverse mortgages of $3.4 billion and $3.6 billion, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(c) | Physical commodities inventories are generally accounted for at the lower of cost or market. “Market” is a term defined in U.S. GAAP as not exceeding fair value less costs to sell (“transaction costs”). Transaction costs for the Firm’s physical commodities inventories are either not applicable or immaterial to the value of the inventory. Therefore, market approximates fair value for the Firm’s physical commodities inventories. When fair value hedging has been applied (or when market is below cost), the carrying value of physical commodities approximates fair value, because under fair value hedge accounting, the cost basis is adjusted for changes in fair value. For a further discussion of the Firm’s hedge accounting relationships, see Note 6. To provide consistent fair value disclosure information, all physical commodities inventories have been included in each period presented. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(d) | Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions). | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(e) | As permitted under U.S. GAAP, the Firm has elected to net derivative receivables and derivative payables and the related cash collateral received and paid when a legally enforceable master netting agreement exists. For purposes of the tables above, the Firm does not reduce derivative receivables and derivative payables balances for this netting adjustment, either within or across the levels of the fair value hierarchy, as such netting is not relevant to a presentation based on the transparency of inputs to the valuation of an asset or liability. Therefore, the balances reported in the fair value hierarchy table are gross of any counterparty netting adjustments. However, if the Firm were to net such balances within level 3, the reduction in the level 3 derivative receivables and payables balances would be $2.5 billion and $7.6 billion at December 31, 2014 and 2013, respectively; this is exclusive of the netting benefit associated with cash collateral, which would further reduce the level 3 balances. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(f) | Private equity instruments represent investments within the Corporate line of business. The cost basis of the private equity investment portfolio totaled $6.0 billion and $8.0 billion at December 31, 2014 and 2013, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(g) | Includes investments in hedge funds, private equity funds, real estate and other funds that do not have readily determinable fair values. The Firm uses net asset value per share when measuring the fair value of these investments. At December 31, 2014 and 2013, the fair values of these investments were $1.8 billion and $3.2 billion, respectively, of which $337 million and $899 million, respectively were classified in level 2, and $1.4 billion and $2.3 billion, respectively, in level 3. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Transfers between levels for instruments carried at fair value on a recurring basis |
For the year ended December 31, 2014 and 2013, there were no significant transfers between levels 1 and 2. |
During the year ended December 31, 2014, transfers from level 3 to level 2 included the following: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $4.3 billion and $4.4 billion of gross equity derivative receivables and payables, respectively, due to increased observability of certain equity option valuation inputs; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $2.7 billion of trading loans, $2.6 billion of margin loans, $2.3 billion of private equity investments, $2.0 billion of corporate debt, and $1.3 billion of long-term debt, based on increased liquidity and price transparency. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Transfers from level 2 into level 3 included $1.1 billion of other borrowed funds, $1.1 billion of trading loans and $1.0 billion of long-term debt, based on a decrease in observability of valuation inputs and price transparency. |
During the year ended December 31, 2013, transfers from level 3 to level 2 included certain highly rated CLOs, including $27.4 billion held in the Firm’s available-for-sale (“AFS”) securities portfolio and $1.4 billion held in the trading portfolio, based on increased liquidity and price transparency; and $1.3 billion of long-term debt, largely driven by an increase in observability of certain equity structured notes. Transfers from level 2 to level 3 included $1.4 billion of corporate debt securities in the trading portfolio largely driven by a decrease in observability for certain credit instruments. |
For the year ended December 31, 2012, $113.9 billion of settled U.S. government agency mortgage-backed securities were transferred from level 1 to level 2. While the U.S. government agency mortgage-backed securities market remained highly liquid and transparent, the transfer reflected greater market price differentiation between settled securities based on certain underlying loan specific factors. There were no significant transfers from level 2 to level 1 for the year ended December 31, 2012. |
For the year ended December 31, 2012, there were no significant transfers from level 2 into level 3. For the year ended December 31, 2012, transfers from level 3 into level 2 included $1.2 billion of derivative payables based on increased observability of certain structured equity derivatives; and $1.8 billion of long-term debt due to increased observability of certain equity structured notes. |
All transfers are assumed to occur at the beginning of the quarterly reporting period in which they occur. |
Level 3 valuations |
The Firm has established well-documented processes for determining fair value, including for instruments where fair value is estimated using significant unobservable inputs (level 3). For further information on the Firm’s valuation process and a detailed discussion of the determination of fair value for individual financial instruments, see pages 181–184 of this Note. |
Estimating fair value requires the application of judgment. The type and level of judgment required is largely dependent on the amount of observable market information available to the Firm. For instruments valued using internally developed models that use significant unobservable inputs and are therefore classified within level 3 of the fair value hierarchy, judgments used to estimate fair value are more significant than those required when estimating the fair value of instruments classified within levels 1 and 2. |
In arriving at an estimate of fair value for an instrument within level 3, management must first determine the appropriate model to use. Second, due to the lack of observability of significant inputs, management must assess all relevant empirical data in deriving valuation inputs including, but not limited to, transaction details, yield curves, interest rates, prepayment speed, default rates, volatilities, correlations, equity or debt prices, valuations of comparable instruments, foreign exchange rates and credit curves. |
The following table presents the Firm’s primary level 3 financial instruments, the valuation techniques used to measure the fair value of those financial instruments, the significant unobservable inputs, the range of values for those inputs and, for certain instruments, the weighted averages of such inputs. While the determination to classify an instrument within level 3 is based on the significance of the unobservable inputs to the overall fair value measurement, level 3 financial instruments typically include observable components (that is, components that are actively quoted and can be validated to external sources) in addition to the unobservable components. The level 1 and/or level 2 inputs are not included in the table. In addition, the Firm manages the risk of the observable components of level 3 financial instruments using securities and derivative positions that are classified within levels 1 or 2 of the fair value hierarchy. |
The range of values presented in the table is representative of the highest and lowest level input used to value the significant groups of instruments within a product/instrument classification. Where provided, the weighted averages of the input values presented in the table are calculated based on the fair value of the instruments that the input is being used to value. |
In the Firm’s view, the input range and the weighted average value do not reflect the degree of input uncertainty or an assessment of the reasonableness of the Firm’s estimates and assumptions. Rather, they reflect the characteristics of the various instruments held by the Firm and the relative distribution of instruments within the range of characteristics. For example, two option contracts may have similar levels of market risk exposure and valuation uncertainty, but may have significantly different implied volatility levels because the option contracts have different underlyings, tenors, or strike prices. The input range and weighted average values will therefore vary from period-to-period and parameter to parameter based on the characteristics of the instruments held by the Firm at each balance sheet date. |
For the Firm’s derivatives and structured notes positions classified within level 3, the equity and interest rate correlation inputs used in estimating fair value were concentrated at the upper end of the range presented, while the credit correlation inputs were distributed across the range presented and the foreign exchange correlation inputs were concentrated at the lower end of the range presented. In addition, the interest rate volatility inputs used in estimating fair value were concentrated at the upper end of the range presented and the foreign exchange correlation inputs were concentrated at the lower end of the range presented. The equity volatility is concentrated in the lower half end of the range. The forward commodity prices used in estimating the fair value of commodity derivatives were concentrated within the lower end of the range presented. |
|
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Level 3 inputs(a) | | | | | | | | | | | | | | | | | | | | | |
December 31, 2014 (in millions, except for ratios and basis points) | | | | | | | | | | | | | | | | | | | | | | | | | |
Product/Instrument | Fair value | | Principal valuation technique | Unobservable inputs | Range of input values | Weighted average | | | | | | | | | | | | | | | | | | | | |
Residential mortgage-backed securities and loans | $ | 8,917 | | | Discounted cash flows | Yield | 1% | | - | 25% | 5% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | Prepayment speed | 0% | | - | 18% | 6% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | Conditional default rate | 0% | | - | 100% | 22% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | Loss severity | 0% | | - | 90% | 27% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Commercial mortgage-backed securities and loans(b) | 5,319 | | | Discounted cash flows | Yield | 2% | | - | 32% | 5% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | Conditional default rate | 0% | | - | 100% | 8% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | Loss severity | 0% | | - | 50% | 29% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Corporate debt securities, obligations of U.S. states and municipalities, and other(c) | 6,387 | | | Discounted cash flows | Credit spread | 53 bps | | - | 270 bps | 140 bps | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | Yield | 1% | | - | 22% | 7% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
6,629 | | | Market comparables | Price | $ | — | | - | $131 | $90 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Net interest rate derivatives | 626 | | | Option pricing | Interest rate correlation | (75 | )% | - | 95% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | Interest rate spread volatility | 0% | | - | 60% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Net credit derivatives(b)(c) | 189 | | | Discounted cash flows | Credit correlation | 47% | | - | 90% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Net foreign exchange derivatives | (526 | ) | | Option pricing | Foreign exchange correlation | 0% | | - | 60% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Net equity derivatives | (1,785 | ) | | Option pricing | Equity volatility | 15% | | - | 65% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Net commodity derivatives | (565 | ) | | Discounted cash flows | Forward commodity price | $ | 50 | | - | $90 per barrel | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Collateralized loan obligations | 792 | | | Discounted cash flows | Credit spread | 260 bps | | - | 675 bps | 279 bps | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | Prepayment speed | 20% | 20% | | | | | | | | | | | | | | | | | | | | |
| | | | Conditional default rate | 2% | 2% | | | | | | | | | | | | | | | | | | | | |
| | | | Loss severity | 40% | 40% | | | | | | | | | | | | | | | | | | | | |
| 393 | | | Market comparables | Price | $ | — | | - | $146 | $79 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Mortgage servicing rights | 7,436 | | | Discounted cash flows | Refer to Note 17 | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Private equity direct investments | 2,054 | | | Market comparables | EBITDA multiple | 6x | | - | 12.4x | 9.1x | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | Liquidity adjustment | 0% | | - | 15% | 7% | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Private equity fund investments | 421 | | | Net asset value | Net asset value(e) | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Long-term debt, other borrowed funds, and deposits(d) | 15,069 | | | Option pricing | Interest rate correlation | (75 | )% | - | 95% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | Interest rate spread volatility | 0% | | - | 60% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | Foreign exchange correlation | 0% | | - | 60% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | Equity correlation | (55 | )% | - | 85% | | | | | | | | | | | | | | | | | | | | | |
| 1,120 | | | Discounted cash flows | Credit correlation | 47% | | - | 90% | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | The categories presented in the table have been aggregated based upon the product type, which may differ from their classification on the Consolidated balance sheets. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(b) | The unobservable inputs and associated input ranges for approximately $491 million of credit derivative receivables and $433 million of credit derivative payables with underlying commercial mortgage risk have been included in the inputs and ranges provided for commercial mortgage-backed securities and loans. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(c) | The unobservable inputs and associated input ranges for approximately $795 million of credit derivative receivables and $715 million of credit derivative payables with underlying asset-backed securities risk have been included in the inputs and ranges provided for corporate debt securities, obligations of U.S. states and municipalities and other. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(d) | Long-term debt, other borrowed funds and deposits include structured notes issued by the Firm that are predominantly financial instruments containing embedded derivatives. The estimation of the fair value of structured notes is predominantly based on the derivative features embedded within the instruments. The significant unobservable inputs are broadly consistent with those presented for derivative receivables. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(e) | The range has not been disclosed due to the wide range of possible values given the diverse nature of the underlying investments. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Changes in and ranges of unobservable inputs |
The following discussion provides a description of the impact on a fair value measurement of a change in each unobservable input in isolation, and the interrelationship between unobservable inputs, where relevant and significant. The impact of changes in inputs may not be independent as a change in one unobservable input may give rise to a change in another unobservable input; where relationships exist between two unobservable inputs, those relationships are discussed below. Relationships may also exist between observable and unobservable inputs (for example, as observable interest rates rise, unobservable prepayment rates decline); such relationships have not been included in the discussion below. In addition, for each of the individual relationships described below, the inverse relationship would also generally apply. |
In addition, the following discussion provides a description of attributes of the underlying instruments and external market factors that affect the range of inputs used in the valuation of the Firm’s positions. |
Yield – The yield of an asset is the interest rate used to discount future cash flows in a discounted cash flow calculation. An increase in the yield, in isolation, would result in a decrease in a fair value measurement. |
Credit spread – The credit spread is the amount of additional annualized return over the market interest rate that a market participant would demand for taking exposure to the credit risk of an instrument. The credit spread for an instrument forms part of the discount rate used in a discounted cash flow calculation. Generally, an increase in the credit spread would result in a decrease in a fair value measurement. |
The yield and the credit spread of a particular mortgage-backed security primarily reflect the risk inherent in the instrument. The yield is also impacted by the absolute level of the coupon paid by the instrument (which may not correspond directly to the level of inherent risk). Therefore, the range of yield and credit spreads reflects the range of risk inherent in various instruments owned by the Firm. The risk inherent in mortgage-backed securities is driven by the subordination of the security being valued and the characteristics of the underlying mortgages within the collateralized pool, including borrower FICO scores, loan-to-value ratios for residential mortgages and the nature of the property and/or any tenants for commercial mortgages. For corporate debt securities, obligations of U.S. states and municipalities and other similar instruments, credit spreads reflect the credit quality of the obligor and the tenor of the obligation. |
Prepayment speed – The prepayment speed is a measure of the voluntary unscheduled principal repayments of a prepayable obligation in a collateralized pool. Prepayment speeds generally decline as borrower delinquencies rise. An increase in prepayment speeds, in isolation, would result in a decrease in a fair value measurement of assets valued at a premium to par and an increase in a fair value measurement of assets valued at a discount to par. |
Prepayment speeds may vary from collateral pool to collateral pool, and are driven by the type and location of the underlying borrower, the remaining tenor of the obligation as well as the level and type (e.g., fixed or floating) of interest rate being paid by the borrower. Typically collateral pools with higher borrower credit quality have a higher prepayment rate than those with lower borrower credit quality, all other factors being equal. |
Conditional default rate – The conditional default rate is a measure of the reduction in the outstanding collateral balance underlying a collateralized obligation as a result of defaults. While there is typically no direct relationship between conditional default rates and prepayment speeds, collateralized obligations for which the underlying collateral has high prepayment speeds will tend to have lower conditional default rates. An increase in conditional default rates would generally be accompanied by an increase in loss severity and an increase in credit spreads. An increase in the conditional default rate, in isolation, would result in a decrease in a fair value measurement. Conditional default rates reflect the quality of the collateral underlying a securitization and the structure of the securitization itself. Based on the types of securities owned in the Firm’s market-making portfolios, conditional default rates are most typically at the lower end of the range presented. |
Loss severity – The loss severity (the inverse concept is the recovery rate) is the expected amount of future realized losses resulting from the ultimate liquidation of a particular loan, expressed as the net amount of loss relative to the outstanding loan balance. An increase in loss severity is generally accompanied by an increase in conditional default rates. An increase in the loss severity, in isolation, would result in a decrease in a fair value measurement. |
The loss severity applied in valuing a mortgage-backed security investment depends on a host of factors relating to the underlying mortgages. This includes the loan-to-value ratio, the nature of the lender’s lien on the property and various other instrument-specific factors. |
Correlation – Correlation is a measure of the relationship between the movements of two variables (e.g., how the change in one variable influences the change in the other). Correlation is a pricing input for a derivative product where the payoff is driven by one or more underlying risks. Correlation inputs are related to the type of derivative (e.g., interest rate, credit, equity and foreign exchange) due to the nature of the underlying risks. When parameters are positively correlated, an increase in one parameter will result in an increase in the other parameter. When parameters are negatively correlated, an increase in one parameter will result in a decrease in the other parameter. An increase in correlation can result in an increase or a decrease in a fair value measurement. Given a short correlation position, an increase in correlation, in isolation, would generally result in a decrease in a fair value measurement. The range of correlation inputs between risks within the same asset class are generally narrower than those between underlying risks across asset classes. In addition, the ranges of credit correlation inputs tend to be narrower than those affecting other asset classes. |
The level of correlation used in the valuation of derivatives with multiple underlying risks depends on a number of factors including the nature of those risks. For example, the correlation between two credit risk exposures would be different than that between two interest rate risk exposures. Similarly, the tenor of the transaction may also impact the correlation input as the relationship between the underlying risks may be different over different time periods. Furthermore, correlation levels are very much dependent on market conditions and could have a relatively wide range of levels within or across asset classes over time, particularly in volatile market conditions. |
Volatility – Volatility is a measure of the variability in possible returns for an instrument, parameter or market index given how much the particular instrument, parameter or index changes in value over time. Volatility is a pricing input for options, including equity options, commodity options, and interest rate options. Generally, the higher the volatility of the underlying, the riskier the instrument. Given a long position in an option, an increase in volatility, in isolation, would generally result in an increase in a fair value measurement. |
The level of volatility used in the valuation of a particular option-based derivative depends on a number of factors, including the nature of the risk underlying the option (e.g., the volatility of a particular equity security may be significantly different from that of a particular commodity index), the tenor of the derivative as well as the strike price of the option. |
EBITDA multiple – EBITDA multiples refer to the input (often derived from the value of a comparable company) that is multiplied by the historic and/or expected earnings before interest, taxes, depreciation and amortization (“EBITDA”) of a company in order to estimate the company’s value. An increase in the EBITDA multiple, in isolation, net of adjustments, would result in an increase in a fair value measurement. |
Net asset value – Net asset value is the total value of a fund’s assets less liabilities. An increase in net asset value would result in an increase in a fair value measurement. |
Changes in level 3 recurring fair value measurements |
The following tables include a rollforward of the Consolidated balance sheets amounts (including changes in fair value) for financial instruments classified by the Firm within level 3 of the fair value hierarchy for the years ended December 31, 2014, 2013 and 2012. When a determination is made to classify a financial instrument within level 3, the determination is based on the significance of the unobservable parameters to the overall fair value measurement. However, level 3 financial instruments typically include, in addition to the unobservable or level 3 components, observable components (that is, components that are actively quoted and can be validated to external sources); accordingly, the gains and losses in the table below include changes in fair value due in part to observable factors that are part of the valuation methodology. Also, the Firm risk-manages the observable components of level 3 financial instruments using securities and derivative positions that are classified within level 1 or 2 of the fair value hierarchy; as these level 1 and level 2 risk management instruments are not included below, the gains or losses in the following tables do not reflect the effect of the Firm’s risk management activities related to such level 3 instruments. |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fair value measurements using significant unobservable inputs | | | | |
Year ended | Fair value at January 1, 2014 | Total realized/unrealized gains/(losses) | | | | | Transfers into and/or out of level 3(h) | Fair value at Dec. 31, 2014 | | Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2014 | | |
31-Dec-14 | | |
(in millions) | Purchases(g) | Sales | | Settlements | | |
Assets: | | | | | | | | | | | | | | |
Trading assets: | | | | | | | | | | | | | | |
Debt instruments: | | | | | | | | | | | | | | |
Mortgage-backed securities: | | | | | | | | | | | | | | |
U.S. government agencies | $ | 1,005 | | $ | (97 | ) | | $ | 351 | | $ | (186 | ) | | $ | (121 | ) | $ | (30 | ) | $ | 922 | | | $ | (92 | ) | | | |
| |
Residential – nonagency | 726 | | 66 | | | 827 | | (761 | ) | | (41 | ) | (154 | ) | 663 | | | (15 | ) | | | |
| |
Commercial – nonagency | 432 | | 17 | | | 980 | | (914 | ) | | (60 | ) | (149 | ) | 306 | | | (12 | ) | | | |
| |
Total mortgage-backed securities | 2,163 | | (14 | ) | | 2,158 | | (1,861 | ) | | (222 | ) | (333 | ) | 1,891 | | | (119 | ) | | | |
| |
Obligations of U.S. states and municipalities | 1,382 | | 90 | | | 298 | | (358 | ) | | (139 | ) | — | | 1,273 | | | (27 | ) | | | |
| |
Non-U.S. government debt securities | 143 | | 24 | | | 719 | | (617 | ) | | (3 | ) | 36 | | 302 | | | 10 | | | | |
| |
Corporate debt securities | 5,920 | | 210 | | | 5,854 | | (3,372 | ) | | (4,531 | ) | (1,092 | ) | 2,989 | | | 379 | | | | |
| |
Loans | 13,455 | | 387 | | | 13,551 | | (7,917 | ) | | (4,623 | ) | (1,566 | ) | 13,287 | | | 123 | | | | |
| |
Asset-backed securities | 1,272 | | 19 | | | 2,240 | | (2,126 | ) | | (283 | ) | 142 | | 1,264 | | | (30 | ) | | | |
| |
Total debt instruments | 24,335 | | 716 | | | 24,820 | | (16,251 | ) | | (9,801 | ) | (2,813 | ) | 21,006 | | | 336 | | | | |
| |
Equity securities | 885 | | 112 | | | 248 | | (272 | ) | | (290 | ) | (252 | ) | 431 | | | 46 | | | | |
| |
Physical commodities | 4 | | (1 | ) | | — | | — | | | (1 | ) | — | | 2 | | | — | | | | |
| |
Other | 2,000 | | 239 | | | 1,426 | | (276 | ) | | (201 | ) | (2,138 | ) | 1,050 | | | 329 | | | | |
| |
Total trading assets – debt and equity instruments | 27,224 | | 1,066 | | (c) | 26,494 | | (16,799 | ) | | (10,293 | ) | (5,203 | ) | 22,489 | | | 711 | | (c) | | |
| |
Net derivative receivables:(a) | | | | | | | | | | | | | | |
Interest rate | 2,379 | | 184 | | | 198 | | (256 | ) | | (1,771 | ) | (108 | ) | 626 | | | (853 | ) | | | |
| |
Credit | 95 | | (149 | ) | | 272 | | (47 | ) | | 92 | | (74 | ) | 189 | | | (107 | ) | | | |
| |
Foreign exchange | (1,200 | ) | (137 | ) | | 139 | | (27 | ) | | 668 | | 31 | | (526 | ) | | (62 | ) | | | |
| |
Equity | (1,063 | ) | 154 | | | 2,044 | | (2,863 | ) | | 10 | | (67 | ) | (1,785 | ) | | 583 | | | | |
| |
Commodity | 115 | | (465 | ) | | 1 | | (113 | ) | | (109 | ) | 6 | | (565 | ) | | (186 | ) | | | |
| |
Total net derivative receivables | 326 | | (413 | ) | (c) | 2,654 | | (3,306 | ) | | (1,110 | ) | (212 | ) | (2,061 | ) | | (625 | ) | (c) | | |
| |
Available-for-sale securities: | | | | | | | | | | | | | | |
Asset-backed securities | 1,088 | | (41 | ) | | 275 | | (2 | ) | | (101 | ) | (311 | ) | 908 | | | (40 | ) | | | |
| |
Other | 1,234 | | (19 | ) | | 122 | | — | | | (223 | ) | (985 | ) | 129 | | | (2 | ) | | | |
| |
Total available-for-sale securities | 2,322 | | (60 | ) | (d) | 397 | | (2 | ) | | (324 | ) | (1,296 | ) | 1,037 | | | (42 | ) | (d) | | |
| |
Loans | 1,931 | | (254 | ) | (c) | 3,258 | | (845 | ) | | (1,549 | ) | — | | 2,541 | | | (234 | ) | (c) | | |
| |
Mortgage servicing rights | 9,614 | | (1,826 | ) | (e) | 768 | | (209 | ) | | (911 | ) | — | | 7,436 | | | (1,826 | ) | (e) | | |
| |
Other assets: | | | | | | | | | | | | | | |
Private equity investments | 6,474 | | 443 | | (c) | 164 | | (1,967 | ) | | (360 | ) | (2,279 | ) | 2,475 | | | 26 | | (c) | | |
| |
All other | 3,176 | | 33 | | (f) | 190 | | (451 | ) | | (577 | ) | — | | 2,371 | | | 11 | | (f) | | |
| |
| | | | | | | | | | | | | | |
| Fair value measurements using significant unobservable inputs | | | | |
Year ended | Fair value at January 1, 2014 | Total realized/unrealized (gains)/losses | | | | | Transfers into and/or out of level 3(h) | Fair value at Dec. 31, 2014 | | Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2014 | | |
31-Dec-14 | | |
(in millions) | Purchases(g) | Sales | Issuances | Settlements | | |
Liabilities:(b) | | | | | | | | | | | | | | |
Deposits | $ | 2,255 | | $ | 149 | | (c) | $ | — | | $ | — | | $ | 1,578 | | $ | (197 | ) | $ | (926 | ) | $ | 2,859 | | | $ | 130 | | (c) | | |
| |
Other borrowed funds | 2,074 | | (596 | ) | (c) | — | | — | | 5,377 | | (6,127 | ) | 725 | | 1,453 | | | (415 | ) | (c) | | |
| |
Trading liabilities – debt and equity instruments | 113 | | (5 | ) | (c) | (305 | ) | 323 | | — | | (5 | ) | (49 | ) | 72 | | | 2 | | (c) | | |
| |
Accounts payable and other liabilities | 25 | | 27 | | (f) | — | | — | | — | | (16 | ) | — | | 36 | | | — | | (f) | | |
| |
Beneficial interests issued by consolidated VIEs | 1,240 | | (4 | ) | (c) | — | | — | | 775 | | (763 | ) | (102 | ) | 1,146 | | | (22 | ) | (c) | | |
| |
Long-term debt | 10,008 | | (40 | ) | (c) | — | | — | | 7,421 | | (5,231 | ) | (281 | ) | 11,877 | | | (9 | ) | (c) | | |
| |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fair value measurements using significant unobservable inputs | | |
Year ended | Fair value at January 1, 2013 | Total realized/unrealized gains/(losses) | | | | | | | Transfers into and/or out of level 3(h) | Fair value at | Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2013 |
31-Dec-13 | Dec. 31, 2013 |
(in millions) | Purchases(g) | | Sales | | | Settlements | |
Assets: | | | | | | | | | | | | | | |
Trading assets: | | | | | | | | | | | | | | |
Debt instruments: | | | | | | | | | | | | | | |
Mortgage-backed securities: | | | | | | | | | | | | | | |
U.S. government agencies | $ | 498 | | $ | 169 | | | $ | 819 | | | $ | (381 | ) | | | $ | (100 | ) | $ | — | | $ | 1,005 | | | $ | 200 | | |
|
Residential – nonagency | 663 | | 407 | | | 780 | | | (1,028 | ) | | | (91 | ) | (5 | ) | 726 | | | 205 | | |
|
Commercial – nonagency | 1,207 | | 114 | | | 841 | | | (1,522 | ) | | | (208 | ) | — | | 432 | | | (4 | ) | |
|
Total mortgage-backed securities | 2,368 | | 690 | | | 2,440 | | | (2,931 | ) | | | (399 | ) | (5 | ) | 2,163 | | | 401 | | |
|
Obligations of U.S. states and municipalities | 1,436 | | 71 | | | 472 | | | (251 | ) | | | (346 | ) | — | | 1,382 | | | 18 | | |
|
Non-U.S. government debt securities | 67 | | 4 | | | 1,449 | | | (1,479 | ) | | | (8 | ) | 110 | | 143 | | | (1 | ) | |
|
Corporate debt securities | 5,308 | | 103 | | | 7,602 | | | (5,975 | ) | | | (1,882 | ) | 764 | | 5,920 | | | 466 | | |
|
Loans | 10,787 | | 665 | | | 10,411 | | | (7,431 | ) | | | (685 | ) | (292 | ) | 13,455 | | | 315 | | |
|
Asset-backed securities | 3,696 | | 191 | | | 1,912 | | | (2,379 | ) | | | (292 | ) | (1,856 | ) | 1,272 | | | 105 | | |
|
Total debt instruments | 23,662 | | 1,724 | | | 24,286 | | | (20,446 | ) | | | (3,612 | ) | (1,279 | ) | 24,335 | | | 1,304 | | |
|
Equity securities | 1,114 | | (41 | ) | | 328 | | | (266 | ) | | | (135 | ) | (115 | ) | 885 | | | 46 | | |
|
Physical Commodities | — | | (4 | ) | | — | | | (8 | ) | | | — | | 16 | | 4 | | | (4 | ) | |
|
Other | 863 | | 558 | | | 659 | | | (95 | ) | | | (120 | ) | 135 | | 2,000 | | | 1,074 | | |
|
Total trading assets – debt and equity instruments | 25,639 | | 2,237 | | (c) | 25,273 | | | (20,815 | ) | | | (3,867 | ) | (1,243 | ) | 27,224 | | | 2,420 | | (c) |
|
Net derivative receivables:(a) | | | | | | | | | | | | | | |
Interest rate | 3,322 | | 1,358 | | | 344 | | | (220 | ) | | | (2,391 | ) | (34 | ) | 2,379 | | | 107 | | |
|
Credit | 1,873 | | (1,697 | ) | | 115 | | | (12 | ) | | | (357 | ) | 173 | | 95 | | | (1,449 | ) | |
|
Foreign exchange | (1,750 | ) | (101 | ) | | 3 | | | (4 | ) | | | 683 | | (31 | ) | (1,200 | ) | | (110 | ) | |
|
Equity | (1,806 | ) | 2,528 | | (i) | 1,305 | | (i) | (2,111 | ) | (i) | | (1,353 | ) | 374 | | (1,063 | ) | | 872 | | |
|
Commodity | 254 | | 816 | | | 105 | | | (3 | ) | | | (1,107 | ) | 50 | | 115 | | | 410 | | |
|
Total net derivative receivables | 1,893 | | 2,904 | | (c) | 1,872 | | | (2,350 | ) | | | (4,525 | ) | 532 | | 326 | | | (170 | ) | (c) |
|
Available-for-sale securities: | | | | | | | | | | | | | | |
Asset-backed securities | 28,024 | | 4 | | | 579 | | | (57 | ) | | | (57 | ) | (27,405 | ) | 1,088 | | | 4 | | |
|
Other | 892 | | 26 | | | 508 | | | (216 | ) | | | (6 | ) | 30 | | 1,234 | | | 25 | | |
|
Total available-for-sale securities | 28,916 | | 30 | | (d) | 1,087 | | | (273 | ) | | | (63 | ) | (27,375 | ) | 2,322 | | | 29 | | (d) |
|
Loans | 2,282 | | 81 | | (c) | 1,065 | | | (191 | ) | | | (1,306 | ) | — | | 1,931 | | | (21 | ) | (c) |
|
Mortgage servicing rights | 7,614 | | 1,612 | | (e) | 2,215 | | | (725 | ) | | | (1,102 | ) | — | | 9,614 | | | 1,612 | | (e) |
|
Other assets: | | | | | | | | | | | | | | |
Private equity investments | 7,181 | | 645 | | (c) | 673 | | | (1,137 | ) | | | (687 | ) | (201 | ) | 6,474 | | | 262 | | (c) |
|
All other | 4,258 | | 98 | | (f) | 272 | | | (730 | ) | | | (722 | ) | — | | 3,176 | | | 53 | | (f) |
|
| | | | | | | | | | | | | | |
| Fair value measurements using significant unobservable inputs | | |
Year ended | Fair value at January 1, 2013 | Total realized/unrealized (gains)/losses | | | | | | | Transfers into and/or out of level 3(h) | Fair value at Dec. 31, 2013 | Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2013 |
31-Dec-13 |
(in millions) | Purchases(g) | | Sales | | Issuances | Settlements |
Liabilities:(b) | | | | | | | | | | | | | | |
Deposits | $ | 1,983 | | $ | (82 | ) | (c) | $ | — | | | $ | — | | | $ | 1,248 | | $ | (222 | ) | $ | (672 | ) | $ | 2,255 | | | $ | (88 | ) | (c) |
|
Other borrowed funds | 1,619 | | (177 | ) | (c) | — | | | — | | | 7,108 | | (6,845 | ) | 369 | | 2,074 | | | 291 | | (c) |
|
Trading liabilities – debt and equity instruments | 205 | | (83 | ) | (c) | (2,418 | ) | | 2,594 | | | — | | (54 | ) | (131 | ) | 113 | | | (100 | ) | (c) |
|
Accounts payable and other liabilities | 36 | | (2 | ) | (f) | — | | | — | | | — | | (9 | ) | — | | 25 | | | (2 | ) | (f) |
|
Beneficial interests issued by consolidated VIEs | 925 | | 174 | | (c) | — | | | — | | | 353 | | (212 | ) | — | | 1,240 | | | 167 | | (c) |
|
Long-term debt | 8,476 | | (435 | ) | (c) | — | | | — | | | 6,830 | | (4,362 | ) | (501 | ) | 10,008 | | | (85 | ) | (c) |
|
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Fair value measurements using significant unobservable inputs | | |
Year ended | Fair value at January 1, 2012 | Total realized/unrealized gains/(losses) | | | | | | | Transfers into and/or out of level 3(h) | Fair value at | Change in unrealized gains/(losses) related to financial instruments held at Dec. 31, 2012 |
31-Dec-12 | Dec. 31, 2012 |
(in millions) | Purchases(g) | | Sales | | | Settlements | |
Assets: | | | | | | | | | | | | | | |
Trading assets: | | | | | | | | | | | | | | |
Debt instruments: | | | | | | | | | | | | | | |
Mortgage-backed securities: | | | | | | | | | | | | | | |
U.S. government agencies | $ | 86 | | $ | (44 | ) | | $ | 575 | | | $ | (103 | ) | | | $ | (16 | ) | $ | — | | $ | 498 | | | $ | (21 | ) | |
|
Residential – nonagency | 796 | | 151 | | | 417 | | | (533 | ) | | | (145 | ) | (23 | ) | 663 | | | 74 | | |
|
Commercial – nonagency | 1,758 | | (159 | ) | | 287 | | | (475 | ) | | | (104 | ) | (100 | ) | 1,207 | | | (145 | ) | |
|
Total mortgage-backed securities | 2,640 | | (52 | ) | | 1,279 | | | (1,111 | ) | | | (265 | ) | (123 | ) | 2,368 | | | (92 | ) | |
|
Obligations of U.S. states and municipalities | 1,619 | | 37 | | | 336 | | | (552 | ) | | | (4 | ) | — | | 1,436 | | | (15 | ) | |
|
Non-U.S. government debt securities | 104 | | (6 | ) | | 661 | | | (668 | ) | | | (24 | ) | — | | 67 | | | (5 | ) | |
|
Corporate debt securities | 6,373 | | 187 | | | 8,391 | | | (6,186 | ) | | | (3,045 | ) | (412 | ) | 5,308 | | | 689 | | |
|
Loans | 12,209 | | 836 | | | 5,342 | | | (3,269 | ) | | | (3,801 | ) | (530 | ) | 10,787 | | | 411 | | |
|
Asset-backed securities | 7,965 | | 272 | | | 2,550 | | | (6,468 | ) | | | (614 | ) | (9 | ) | 3,696 | | | 184 | | |
|
Total debt instruments | 30,910 | | 1,274 | | | 18,559 | | | (18,254 | ) | | | (7,753 | ) | (1,074 | ) | 23,662 | | | 1,172 | | |
|
Equity securities | 1,177 | | (209 | ) | | 460 | | | (379 | ) | | | (12 | ) | 77 | | 1,114 | | | (112 | ) | |
|
Other | 880 | | 186 | | | 68 | | | (108 | ) | | | (163 | ) | — | | 863 | | | 180 | | |
|
Total trading assets – debt and equity instruments | 32,967 | | 1,251 | | (c) | 19,087 | | | (18,741 | ) | | | (7,928 | ) | (997 | ) | 25,639 | | | 1,240 | | (c) |
|
Net derivative receivables:(a) | | | | | | | | | | | | | | |
Interest rate | 3,561 | | 6,930 | | | 406 | | | (194 | ) | | | (7,071 | ) | (310 | ) | 3,322 | | | 905 | | |
|
Credit | 7,732 | | (4,487 | ) | | 124 | | | (84 | ) | | | (1,416 | ) | 4 | | 1,873 | | | (3,271 | ) | |
|
Foreign exchange | (1,263 | ) | (800 | ) | | 112 | | | (184 | ) | | | 436 | | (51 | ) | (1,750 | ) | | (957 | ) | |
|
Equity | (3,105 | ) | 160 | | (i) | 1,279 | | (i) | (2,174 | ) | (i) | | 899 | | 1,135 | | (1,806 | ) | | 580 | | |
|
Commodity | (687 | ) | (673 | ) | | 74 | | | 64 | | | | 1,278 | | 198 | | 254 | | | (160 | ) | |
|
Total net derivative receivables | 6,238 | | 1,130 | | (c) | 1,995 | | | (2,572 | ) | | | (5,874 | ) | 976 | | 1,893 | | | (2,903 | ) | (c) |
|
Available-for-sale securities: | | | | | | | | | | | | | | |
Asset-backed securities | 24,958 | | 135 | | | 9,280 | | | (3,361 | ) | | | (3,104 | ) | 116 | | 28,024 | | | 118 | | |
|
Other | 528 | | 55 | | | 667 | | | (113 | ) | | | (245 | ) | — | | 892 | | | 59 | | |
|
Total available-for-sale securities | 25,486 | | 190 | | (d) | 9,947 | | | (3,474 | ) | | | (3,349 | ) | 116 | | 28,916 | | | 177 | | (d) |
|
Loans | 1,647 | | 695 | | (c) | 1,536 | | | (22 | ) | | | (1,718 | ) | 144 | | 2,282 | | | 12 | | (c) |
|
Mortgage servicing rights | 7,223 | | (635 | ) | (e) | 2,833 | | | (579 | ) | | | (1,228 | ) | — | | 7,614 | | | (635 | ) | (e) |
|
Other assets: | | | | | | | | | | | | | | |
Private equity investments | 6,751 | | 420 | | (c) | 1,545 | | | (512 | ) | | | (977 | ) | (46 | ) | 7,181 | | | 333 | | (c) |
|
All other | 4,374 | | (195 | ) | (f) | 818 | | | (238 | ) | | | (501 | ) | — | | 4,258 | | | (200 | ) | (f) |
|
| | | | | | | | | | | | | | |
| Fair value measurements using significant unobservable inputs | | |
Year ended | Fair value at January 1, 2012 | Total realized/unrealized (gains)/losses | | | | | | | Transfers into and/or out of level 3(h) | Fair value at Dec. 31, 2012 | Change in unrealized (gains)/losses related to financial instruments held at Dec. 31, 2012 |
31-Dec-12 |
(in millions) | Purchases(g) | | Sales | | Issuances | Settlements |
Liabilities:(b) | | | | | | | | | | | | | | |
Deposits | $ | 1,418 | | $ | 212 | | (c) | $ | — | | | $ | — | | | $ | 1,236 | | $ | (380 | ) | $ | (503 | ) | $ | 1,983 | | | $ | 185 | | (c) |
|
Other borrowed funds | 1,507 | | 148 | | (c) | — | | | — | | | 1,646 | | (1,774 | ) | 92 | | 1,619 | | | 72 | | (c) |
|
Trading liabilities – debt and equity instruments | 211 | | (16 | ) | (c) | (2,875 | ) | | 2,940 | | | — | | (50 | ) | (5 | ) | 205 | | | (12 | ) | (c) |
|
Accounts payable and other liabilities | 51 | | 1 | | (f) | — | | | — | | | — | | (16 | ) | — | | 36 | | | 1 | | (f) |
|
Beneficial interests issued by consolidated VIEs | 791 | | 181 | | (c) | — | | | — | | | 221 | | (268 | ) | — | | 925 | | | 143 | | (c) |
|
Long-term debt | 10,310 | | 328 | | (c) | — | | | — | | | 3,662 | | (4,511 | ) | (1,313 | ) | 8,476 | | | (101 | ) | (c) |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | All level 3 derivatives are presented on a net basis, irrespective of underlying counterparty. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(b) | Level 3 liabilities as a percentage of total Firm liabilities accounted for at fair value (including liabilities measured at fair value on a nonrecurring basis) were 15%, 18% and 18% at December 31, 2014, 2013 and 2012, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(c) | Predominantly reported in principal transactions revenue, except for changes in fair value for CCB mortgage loans, lending-related commitments originated with the intent to sell, and mortgage loan purchase commitments, which are reported in mortgage fees and related income. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(d) | Realized gains/(losses) on AFS securities, as well as other-than-temporary impairment losses that are recorded in earnings, are reported in securities gains. Unrealized gains/(losses) are reported in Other Comprehensive Income (“OCI”). Realized gains/(losses) and foreign exchange remeasurement adjustments recorded in income on AFS securities were $(43) million, $17 million, and $145 million for the years ended December 31, 2014, 2013 and 2012, respectively. Unrealized gains/(losses) recorded on AFS securities in OCI were $(16) million, $13 million and $45 million for the years ended December 31, 2014, 2013 and 2012, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(e) | Changes in fair value for CCB mortgage servicing rights are reported in mortgage fees and related income. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(f) | Predominantly reported in other income. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(g) | Loan originations are included in purchases. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(h) | All transfers into and/or out of level 3 are assumed to occur at the beginning of the quarterly reporting period in which they occur. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(i) | The prior period amounts have been revised. The revision had no impact on the Firm’s Consolidated balance sheets or its results of operations. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Level 3 analysis |
Consolidated balance sheets changes |
Level 3 assets (including assets measured at fair value on a nonrecurring basis) were 2.1% of total Firm assets at December 31, 2014. The following describes significant changes to level 3 assets since December 31, 2013, for those items measured at fair value on a recurring basis. For further information on changes impacting items measured at fair value on a nonrecurring basis, see Assets and liabilities measured at fair value on a nonrecurring basis on page 197. |
For the year ended December 31, 2014 |
Level 3 assets were $50.9 billion at December 31, 2014, reflecting a decrease of $18.4 billion from December 31, 2013, due to the following: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $6.0 billion decrease in gross derivative receivables due to a $4.5 billion decrease in equity derivative receivables due to expirations and a transfer from level 3 into level 2 as a result of an increase in observability of certain equity option valuation inputs; and a | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
$1.2 billion decrease in interest rate derivatives due to market movements; |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $4.7 billion decrease in trading assets - debt and equity instruments is largely due to a decrease of $2.9 billion in corporate debt securities. The decrease in corporate debt securities is driven by transfers from level 3 to level 2 as a result of an increase in observability of certain valuation inputs, as well as net sales and maturities; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $4.0 billion decrease in private equity investments predominantly driven by $2.0 billion in sales and $2.3 billion of transfers into level 2 based on an increase in observability and price transparency; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $2.2 billion decrease in MSRs. For further discussion of the change, refer to Note 17. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Gains and losses |
The following describes significant components of total realized/unrealized gains/(losses) for instruments measured at fair value on a recurring basis for the years ended December 31, 2014, 2013 and 2012. For further information on these instruments, see Changes in level 3 recurring fair value measurements rollforward tables on pages 191–195. |
2014 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $1.8 billion of losses on MSRs. For further discussion of the change, refer to Note 17; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $1.1 billion of net gains on trading assets - debt and equity instruments, largely driven by market movements and client-driven financing transactions. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2013 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $2.9 billion of net gains on derivatives, largely driven by $2.5 billion of gains on equity derivatives, primarily related to client-driven market-making activity and a rise in equity markets; and $1.4 billion of gains, predominantly on interest rate lock and mortgage loan purchase commitments; partially offset by $1.7 billion of losses on credit derivatives from the impact of tightening reference entity credit spreads; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $2.2 billion of net gains on trading assets - debt and equity instruments, largely driven by market making and credit spread tightening in nonagency mortgage-backed securities and trading loans, and the impact of market movements on client-driven financing transactions; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $1.6 billion of net gains on MSRs. For further discussion of the change, refer to Note 17. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
2012 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $1.3 billion of net gains on trading assets - debt and equity instruments, largely driven by tightening of credit spreads and fluctuation in foreign exchange rates; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• $1.1 billion of net gains on derivatives, driven by |
$6.9 billion of net gains predominantly on interest rate lock commitments due to increased volumes and lower interest rates, partially offset by $4.5 billion of net losses on credit derivatives largely as a result of tightening of reference entity credit spreads. |
Credit and funding adjustments |
When determining the fair value of an instrument, it may be necessary to record adjustments to the Firm’s estimates of fair value in order to reflect counterparty credit quality, the Firm’s own creditworthiness, and the impact of funding: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | Credit valuation adjustments (“CVA”) are taken to reflect the credit quality of a counterparty in the valuation of derivatives. CVA are necessary when the market price (or parameter) is not indicative of the credit quality of the counterparty. As few classes of derivative contracts are listed on an exchange, derivative positions are predominantly valued using models that use as their basis observable market parameters. An adjustment therefore may be necessary to reflect the credit quality of each derivative counterparty to arrive at fair value. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The Firm estimates derivatives CVA using a scenario analysis to estimate the expected credit exposure across all of the Firm’s positions with each counterparty, and then estimates losses as a result of a counterparty credit event. The key inputs to this methodology are (i) the expected positive exposure to each counterparty based on a simulation that assumes the current population of existing derivatives with each counterparty remains unchanged and considers contractual factors designed to mitigate the Firm’s credit exposure, such as collateral and legal rights of offset; (ii) the probability of a default event occurring for each counterparty, as derived from observed or estimated CDS spreads; and (iii) estimated recovery rates implied by CDS, adjusted to consider the differences in recovery rates as a derivative creditor relative to those reflected in CDS spreads, which generally reflect senior unsecured creditor risk. As such, the Firm estimates derivatives CVA relative to the relevant benchmark interest rate. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | DVA is taken to reflect the credit quality of the Firm in the valuation of liabilities measured at fair value. The DVA calculation methodology is generally consistent with the CVA methodology described above and incorporates JPMorgan Chase’s credit spread as observed through the CDS market to estimate the probability of default and loss given default as a result of a systemic event affecting the Firm. Structured notes DVA is estimated using the current fair value of the structured note as the exposure amount, and is otherwise consistent with the derivative DVA methodology. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The Firm incorporates the impact of funding in its valuation estimates where there is evidence that a market participant in the principal market would incorporate it in a transfer of the instrument. As a result, the fair value of collateralized derivatives is estimated by discounting expected future cash flows at the relevant overnight indexed swap (“OIS”) rate given the underlying collateral agreement with the counterparty. Effective in 2013, the Firm implemented a FVA framework to incorporate the impact of funding into its valuation estimates for uncollateralized (including partially collateralized) over-the-counter (“OTC”) derivatives and structured notes. The Firm’s FVA framework leverages its existing CVA and DVA calculation methodologies, and considers the fact that the Firm’s own credit risk is a significant component of funding costs. The key inputs are: (i) the expected funding requirements arising from the Firm’s positions with each counterparty and collateral arrangements; (ii) for assets, the estimated market funding cost in the principal market; and (iii) for liabilities, the hypothetical market funding cost for a transfer to a market participant with a similar credit standing as the Firm. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Upon the implementation of the FVA framework in 2013, the Firm recorded a one time $1.5 billion loss in principal transactions revenue that was recorded in the CIB. While the FVA framework applies to both assets and liabilities, the loss on implementation largely related to uncollateralized derivative receivables given that the impact of the Firm’s own credit risk, which is a significant component of funding costs, was already incorporated in the valuation of liabilities through the application of DVA. |
The following table provides the credit and funding adjustments, excluding the effect of any associated hedging activities, reflected within the Consolidated balance sheets as of the dates indicated. |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
December 31, (in millions) | 2014 | | 2013 | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivative receivables balance(a) | $ | 78,975 | | | $ | 65,759 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Derivative payables balance(a) | 71,116 | | | 57,314 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives CVA(b) | (2,674 | ) | | (2,352 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives DVA and FVA(b)(c) | (380 | ) | | (322 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Structured notes balance (a)(d) | 53,772 | | | 48,808 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Structured notes DVA and FVA(b)(e) | 1,152 | | | 952 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | Balances are presented net of applicable CVA and DVA/FVA. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(b) | Positive CVA and DVA/FVA represent amounts that increased receivable balances or decreased payable balances; negative CVA and DVA/FVA represent amounts that decreased receivable balances or increased payable balances. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(c) | At December 31, 2014 and 2013, included derivatives DVA of $714 million and $715 million, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(d) | Structured notes are predominantly financial instruments containing embedded derivatives that are measured at fair value based on the Firm’s election under the fair value option. At December 31, 2014 and 2013, included $943 million and $1.1 billion, respectively, of financial instruments with no embedded derivative for which the fair value option has also been elected. For further information on these elections, see Note 4. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(e) | At December 31, 2014 and 2013, included structured notes DVA of $1.4 billion and $1.4 billion, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following table provides the impact of credit and funding adjustments on Principal transactions revenue in the respective periods, excluding the effect of any associated hedging activities. |
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year ended December 31, | 2014 | | 2013 | | 2012 | | | | | | | | | | | | | | | | | | | | | |
(in millions) | | | | | | | | | | | | | | | | | | | | | |
Credit adjustments: | | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivatives CVA | $ | (322 | ) | | $ | 1,886 | | | $ | 2,698 | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Derivatives DVA and FVA(a) | (58 | ) | | (1,152 | ) | | (590 | ) | | | | | | | | | | | | | | | | | | | | | |
Structured notes DVA and FVA(b) | 200 | | | (760 | ) | | (340 | ) | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | Included derivatives DVA of $(1) million, $(115) million and $(590) million for the years ended December 31, 2014, 2013 and 2012, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(b) | Included structured notes DVA of $20 million, $(337) million and $(340) million for the years ended December 31, 2014, 2013 and 2012, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Assets and liabilities measured at fair value on a nonrecurring basis |
At December 31, 2014 and 2013, assets measured at fair value on a nonrecurring basis were $4.5 billion and $6.2 billion, respectively, comprised predominantly of loans that had fair value adjustments for the year ended December 31, 2014. At December 31, 2014, $1.3 billion and $3.2 billion of these assets were classified in levels 2 and 3 of the fair value hierarchy, respectively. At December 31, 2013, $339 million and $5.8 billion of these assets were classified in levels 2 and 3 of the fair value hierarchy, respectively. Liabilities measured at fair value on a nonrecurring basis were not significant at December 31, 2014 and 2013. For the years ended December 31, 2014, 2013 and 2012, there were no significant transfers between levels 1, 2 |
and 3. |
Of the $3.2 billion of the level 3 assets measured at fair value on a nonrecurring basis as of December 31, 2014: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $1.6 billion related to consumer loans that were reclassified to held-for-sale during the fourth quarter of 2014 subject to a lower of cost or fair value adjustment. These loans were classified as level 3, as they are valued based on the Firm’s internal valuation methodology; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | $809 million related to residential real estate loans carried at the net realizable value of the underlying collateral (i.e., collateral-dependent loans and other loans charged off in accordance with regulatory guidance). These amounts are classified as level 3, as they are valued using a broker’s price opinion and discounted based upon the Firm’s experience with actual liquidation values. These discounts to the broker price opinions ranged from 8% to 66%, with a weighted average of 26%. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The total change in the recorded value of assets and liabilities for which a fair value adjustment has been included in the Consolidated statements of income for the years ended December 31, 2014, 2013 and 2012, related to financial instruments held at those dates were losses of $992 million, $789 million and $1.6 billion, respectively; these reductions were predominantly associated with loans. |
For further information about the measurement of impaired collateral-dependent loans, and other loans where the carrying value is based on the fair value of the underlying collateral (e.g., residential mortgage loans charged off in accordance with regulatory guidance), see Note 14. |
Additional disclosures about the fair value of financial instruments that are not carried on the Consolidated balance sheets at fair value |
U.S. GAAP requires disclosure of the estimated fair value of certain financial instruments, and the methods and significant assumptions used to estimate their fair value. Financial instruments within the scope of these disclosure requirements are included in the following table. However, certain financial instruments and all nonfinancial instruments are excluded from the scope of these disclosure requirements. Accordingly, the fair value disclosures provided in the following table include only a partial estimate of the fair value of JPMorgan Chase’s assets and liabilities. For example, the Firm has developed long-term relationships with its customers through its deposit base and credit card accounts, commonly referred to as core deposit intangibles and credit card relationships. In the opinion of management, these items, in the aggregate, add significant value to JPMorgan Chase, but their fair value is not disclosed in this Note. |
Financial instruments for which carrying value approximates fair value |
Certain financial instruments that are not carried at fair value on the Consolidated balance sheets are carried at amounts that approximate fair value, due to their short-term nature and generally negligible credit risk. These instruments include cash and due from banks; deposits with banks; federal funds sold; securities purchased under resale agreements and securities borrowed with short-dated maturities; short-term receivables and accrued interest receivable; commercial paper; federal funds purchased; securities loaned and sold under repurchase agreements with short-dated maturities; other borrowed funds; accounts payable; and accrued liabilities. In addition, U.S. GAAP requires that the fair value of deposit liabilities with no stated maturity (i.e., demand, savings and certain money market deposits) be equal to their carrying value; recognition of the inherent funding value of these instruments is not permitted. |
The following table presents by fair value hierarchy classification the carrying values and estimated fair values at December 31, 2014 and 2013, of financial assets and liabilities, excluding financial instruments which are carried at fair value on a recurring basis. For additional information regarding the financial instruments within the scope of this disclosure, and the methods and significant assumptions used to estimate their fair value, see pages 181–184 of this Note. |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2014 | | 31-Dec-13 | |
| | Estimated fair value hierarchy | | | | Estimated fair value hierarchy | | |
(in billions) | Carrying | Level 1 | Level 2 | Level 3 | Total estimated | | Carrying | Level 1 | Level 2 | Level 3 | Total estimated | |
value | fair value | value | fair value | |
Financial assets | | | | | | | | | | | | |
Cash and due from banks | $ | 27.8 | | $ | 27.8 | | $ | — | | $ | — | | $ | 27.8 | | | $ | 39.8 | | $ | 39.8 | | $ | — | | $ | — | | $ | 39.8 | | |
|
Deposits with banks | 484.5 | | 480.4 | | 4.1 | | — | | 484.5 | | | 316.1 | | 309.7 | | 6.4 | | — | | 316.1 | | |
|
Accrued interest and accounts receivable | 70.1 | | — | | 70 | | 0.1 | | 70.1 | | | 65.2 | | — | | 64.9 | | 0.3 | | 65.2 | | |
|
Federal funds sold and securities purchased under resale agreements | 187.2 | | — | | 187.2 | | — | | 187.2 | | | 223 | | — | | 223 | | — | | 223 | | |
|
Securities borrowed | 109.4 | | — | | 109.4 | | — | | 109.4 | | | 107.7 | | — | | 107.7 | | — | | 107.7 | | |
|
Securities, held-to-maturity(a) | 49.3 | | — | | 51.2 | | — | | 51.2 | | | 24 | | — | | 23.7 | | — | | 23.7 | | |
|
Loans, net of allowance for loan losses(b) | 740.5 | | — | | 21.8 | | 723.1 | | 744.9 | | | 720.1 | | — | | 23 | | 697.2 | | 720.2 | | |
|
Other(c) | 58.1 | | — | | 55.7 | | 7.1 | | 62.8 | | | 58.2 | | — | | 54.5 | | 7.4 | | 61.9 | | |
|
Financial liabilities | | | | | | | | | | | | |
Deposits | $ | 1,354.60 | | $ | — | | $ | 1,353.60 | | $ | 1.2 | | $ | 1,354.80 | | | $ | 1,281.10 | | $ | — | | $ | 1,280.30 | | $ | 1.2 | | $ | 1,281.50 | | |
|
Federal funds purchased and securities loaned or sold under repurchase agreements | 189.1 | | — | | 189.1 | | — | | 189.1 | | | 175.7 | | — | | 175.7 | | — | | 175.7 | | |
|
Commercial paper | 66.3 | | — | | 66.3 | | — | | 66.3 | | | 57.8 | | — | | 57.8 | | — | | 57.8 | | |
|
Other borrowed funds | 15.5 | | | | 15.5 | | — | | 15.5 | | | 14.7 | | — | | 14.7 | | — | | 14.7 | | |
|
Accounts payable and other liabilities | 176.7 | | — | | 173.7 | | 2.8 | | 176.5 | | | 160.2 | | — | | 158.2 | | 1.8 | | 160 | | |
|
Beneficial interests issued by consolidated VIEs | 50.2 | | — | | 48.2 | | 2 | | 50.2 | | | 47.6 | | — | | 44.3 | | 3.2 | | 47.5 | | |
|
Long-term debt and junior subordinated deferrable interest debentures(d) | 246.6 | | — | | 251.6 | | 3.8 | | 255.4 | | | 239 | | — | | 240.8 | | 6 | | 246.8 | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | Carrying value includes unamortized discount or premium. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(b) | Fair value is typically estimated using a discounted cash flow model that incorporates the characteristics of the underlying loans (including principal, contractual interest rate and contractual fees) and other key inputs, including expected lifetime credit losses, interest rates, prepayment rates, and primary origination or secondary market spreads. For certain loans, the fair value is measured based on the value of the underlying collateral. The difference between the estimated fair value and carrying value of a financial asset or liability is the result of the different methodologies used to determine fair value as compared with carrying value. For example, credit losses are estimated for a financial asset’s remaining life in a fair value calculation but are estimated for a loss emergence period in the allowance for loan loss calculation; future loan income (interest and fees) is incorporated in a fair value calculation but is generally not considered in the allowance for loan losses. For a further discussion of the Firm’s methodologies for estimating the fair value of loans and lending-related commitments, see Valuation hierarchy on pages 181–184. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(c) | Current period amounts have been updated to include certain nonmarketable equity securities. Prior period amounts have been revised to conform to the current presentation. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(d) | Carrying value includes unamortized original issue discount and other valuation adjustments. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The majority of the Firm’s lending-related commitments are not carried at fair value on a recurring basis on the Consolidated balance sheets, nor are they actively traded. The carrying value and estimated fair value of the Firm’s wholesale lending-related commitments were as follows for the periods indicated. |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2014 | | 31-Dec-13 | |
| | Estimated fair value hierarchy | | | | Estimated fair value hierarchy | | |
(in billions) | Carrying value(a) | Level 1 | Level 2 | Level 3 | Total estimated fair value | | Carrying value(a) | Level 1 | Level 2 | Level 3 | Total estimated fair value | |
Wholesale lending-related commitments | $ | 0.6 | | $ | — | | $ | — | | $ | 1.6 | | $ | 1.6 | | | $ | 0.7 | | $ | — | | $ | — | | $ | 1 | | $ | 1 | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | Represents the allowance for wholesale lending-related commitments. Excludes the current carrying values of the guarantee liability and the offsetting asset, each of which are recognized at fair value at the inception of guarantees. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
The Firm does not estimate the fair value of consumer lending-related commitments. In many cases, the Firm can reduce or cancel these commitments by providing the borrower notice or, in some cases as permitted by law, without notice. For a further discussion of the valuation of lending-related commitments, see page 182 of this Note. |
Trading assets and liabilities |
Trading assets include debt and equity instruments owned by JPMorgan Chase (“long” positions) that are held for client market-making and client-driven activities, as well as for certain risk management activities, certain loans managed on a fair value basis and for which the Firm has elected the fair value option, and physical commodities inventories that are generally accounted for at the lower of cost or market (market approximates fair value). Trading liabilities include debt and equity instruments that the Firm has sold to other parties but does not own (“short” positions). The Firm is obligated to purchase instruments at a future date to cover the short positions. Included in trading assets and trading liabilities are the reported receivables (unrealized gains) and payables (unrealized losses) related to derivatives. Trading assets and liabilities are carried at fair value on the Consolidated balance sheets. Balances reflect the reduction of securities owned (long positions) by the amount of identical securities sold but not yet purchased (short positions). |
|
Trading assets and liabilities – average balances |
Average trading assets and liabilities were as follows for the periods indicated. |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Year ended December 31, (in millions) | | 2014 | | 2013 | | 2012 | | | | | | | | | | | | | | | | | | | | |
Trading assets – debt and equity instruments | | $ | 327,259 | | | $ | 340,449 | | | $ | 349,337 | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Trading assets – derivative receivables | | 67,123 | | | 72,629 | | | 85,744 | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Trading liabilities – debt and equity instruments(a) | | 84,707 | | | 77,706 | | | 69,001 | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
Trading liabilities – derivative payables | | 54,758 | | | 64,553 | | | 76,162 | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(a) | Primarily represent securities sold, not yet purchased. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |